ProImmune - Mastering Immunity | MHC pentamers, CD1d tetramers, custom peptide synthesis, immunoassays, T cell epitope discovery, HLA tissue typing, cellular analysis, ligand binding assays, immune response

Mastering Immunity

ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses. Our unique innovative solutions for preclinical and clinical immunology research help you take your studies to success through responsive service and focused application support, saving you time and money and reducing risk.

Our Story     Our Clients


Request a Quote

Subscribe to Email Newsletters


USA/Canada Toll free: + 1 888 505 7765

All other countries: + 44 870 042 7279


Video Content

Mastering Immunity Conferences

Dr. Ethan Shevach


"Tregs -ready for the clinic?"

Dr. Timothy Hickling

Pfizer, Inc.

Contribution of ex vivo assays to immunogenicity risk assessment

Dr. Gene Olinger


“Development of a monoclonal antibody cocktail for Ebola virus therapy: convergence of plants, mice, and humans”

Prof. Herman Waldmann

University of Oxford

Tolerance can be induced in the adult immune system

Prof. David Wraith

University of Bristol

“Switching off immunity: the mechanism of antigen-specific immunotherapy”

Dr. Susan Kirshner


Therapeutic Proteins: Route of exposure and immunogenicity risk

Prof. Jean Rommelaere

DKFZ, Germany

“Use of oncolytic parvoviruses in the treatment of malignant gliomas: a viro-immunotherapeutic approach”

Watch More Content


Pro5® MHC Pentamers for T Cell detection

ProVE® Class I MHC Pentamer Libraries

New: ProT2™ MHC Class II Tetramers

ProM2™ MHC Class II Monomers

CD1d Tetramers for NKT Cell detection

ProMix™ Immunodominant Peptide Pools

thinkpeptides®: Custom Peptide Synthesis

Services (by application)

Immunogenicity in Drug Development


Antigen Characterization

Immune Monitoring

Services (by assay)

ProPresent® Antigen Presentation Assay

ProSentium™ Antigen Presentation Data

Naïve T Cell Proliferation Assays

DC-T Cell Proliferation Assays

MHC I Binding Assays

MHC II Binding Assays

MHC II Binding Competition Assays

Prostorm® Cytokine Release Assay

ELISPOT Assay Service

Flow Cytometry Assay Service

ProArray Ultra® Ligand Binding Assays

ProArray Ultra® B-Cell Epitope Mapping

typeHLA Tissue Typing Service

Special Assay Service



Latest News

Introducing: ProT2™ MHC Class II Tetramer reagents to study antigen-specific CD4+ T cell immune responses

Join us in Oxford on March 21, 2016 for Mastering Immunity Europe 2016 a focussed one-day conference to learn the latest developments in the fast-moving area of biological drugs, immunotherapies and vaccines.

Mastering Immunity 5, the latest conference held by ProImmune, was a huge success - the videos from this year's conference are now live

Webcast: ProStorm® Cytokine Release Assay: how does it work?

Meet ProImmune at the following events in 2016:

PEPTALK, San Diego, CA, USA, Jan 18-22

GTC 4th Immunogenicity & Immunotoxicity Conference, San Diego, CA, USA, Jan 25-26

EIP 2016, Algarve, Portugal, Feb 22-24

PEGS 2016, Boston, MA, USA, Apr 25-29

Customer testimonials

Latest customer publications

Pro5® MHC Pentamers used in study published by scientists at Genentech to demonstrate that cross presentation is more efficient that direct presentation of influenza A virus

Figure from: Smed-Sörensen A, Chalouni C, Chatterjee B, Cohn L, et al. (2012) Influenza A Virus Infection of Human Primary Dendritic Cells Impairs Their Ability to Cross-Present Antigen to CD8 T Cells. PLoS Pathog 8(3): e1002572. doi:10.1371/journal.ppat.1002572





Product Information Sheets

Free Resources & Downloads

Peptides Information Poster

Peptides eBook

Pentamer Catalog Pentamer Handbook
Pro5® Pentamer catalog Pro5® Pentamer Handbook